DeoxIT Flux Wash, DFW-V710

Hazard statements (CLP)

H223

Code

Statements

H223

Flammable aerosol

SECTION 2: Hazards identification

This product is classified as a hazardous substance and as a dangerous good according to the classification criteria of NOHSC and ADG Code (Australia). WARNING! Flammable aerosol. Contents under pressure. Do not puncture or incinerate. Keep away from heat, sparks, and flame. Use only with adequate ventilation. Keep containers closed when not in use. Gross inhalation over exposure may cause central nervous system depression.

Hazard statements

H) H223 – Flammable aerosol

Precautionary statements

P210 – Keep away from het/sparks/open flames/hot surfaces – No Smoking. P211 – Do not spray on an open flame or other ignition source. P251 – Pressurized container: do not pierce or burn, even after use. P280 – Wear protective gloves and eye protection. P302 + P352 – IF ON SKIN – Wash with plenty of soap and water. P312 – Call a Poison Control Center or doctor/physician if you feel unwell. P333 + P313 – If skin irritation or rash occurs, get medical advise/attention. P321 – Refer to section 4 of this Safety Data Sheet (First Aid). P305+P351+P338 – IF IN EYES - Rinse continuously with water for several minutes. Remove contact lenses if present and easy to do – continue rinsing. P410 + P412 – Protect from sunlight. Do not expose to temperatures exceeding 50 ºC (122 ºF). P501 – Dispose of contents/container through licensed treatment, storage or disposal facility. Routes of Entry: Inhalation: YES Absorption: YES Ingestion: NO Effects of Exposure: EYES: "Frostbite-like" effects may occur if the liquid or escaping vapors contact the eyes. Mists may cause irritation. SKIN: "Frostbite-like" effects may occur if the liquid or escaping vapors contact the skin. Mists may cause irritation. INGESTION: Not considered to be a potential route of exposure. INHALATION: Gross overexposure may cause central nervous system depression, dizziness, confusion, drowsiness, irregular heartbeat accompanied by a strange feeling in the chest, “heart thumping,” apprehension, light-headedness, weakness, fainting, loss of consciousness, and death. 2.4 Symptoms of Exposure: EYES: No exposure symptoms are reported by the manufacturer. SKIN: No exposure symptoms are reported by the manufacturer. INGESTION: Not considered to be a potential route of exposure. INHALATION: Dizziness, confusion, drowsiness, irregular heartbeat accompanied by a strange feeling in the chest, “heart thumping”, apprehension, light-headedness, weakness, fainting, loss of consciousness, and death. 2.5

Potential Acute Health Effects

EYES: "Frostbite-like" effects may occur if the liquid or escaping vapors contact the eyes. Mists may cause irritation. SKIN: "Frostbite-like" effects may occur if the liquid or escaping vapors contact the skin. Mists may cause irritation. INGESTION: Not considered to be a potential route of exposure. INHALATION: Gross overexposure may cause central nervous system depression, dizziness, confusion, drowsiness, irregular heartbeat accompanied by a strange feeling in the chest, “heart thumping”, apprehension, light-headedness, weakness, fainting, loss of consciousness, and death. 2.6

Potential chronic health

The manufacturer has not reported any chronic health effects. 2.7 Target Organs: None reported by the manufacturer. 2.8 Toxicological Properties: None reported by the manufacturer. NA = Not Available; ND = Not Determined; NE = Not Established; C = Ceiling Limit; See Section 16 for Additional Definitions of Terms Used NOTE: all WHMIS required information is included. It is located in appropriate sections based on the ANSI Z400.1-2010 format.